En rekombinant version av löslig humant TNF-receptor som binder specifikt till tumörnekrosfaktorer och hämmar bindning till endogena TNF-receptorer. Den hindrar den inflammatoriska effekten av TNF och används för att behandla ledgångsreumatism, psoriasisartrit och ankyloserande spondylit.
A recombinant version of soluble human TNF receptor fused to an IgG FC fragment that binds specifically to TUMOR NECROSIS FACTOR and inhibits its binding with endogenous TNF receptors. It prevents the inflammatory effect of TNF and is used to treat RHEUMATOID ARTHRITIS; PSORIATIC ARTHRITIS and ANKYLOSING SPONDYLITIS.
Enbrel
TNF Receptor Type II-IgG Fusion Protein — TNF Receptor Type II IgG Fusion Protein — Enbrel — TNFR-Fc Fusion Protein — Fusion Protein, TNFR-Fc — TNFR Fc Fusion Protein — TNTR-Fc — TNR 001 — TNR-001 — TNR001 — TNT Receptor Fusion Protein — Erelzi — Etanercept-szzs — Recombinant Human Dimeric TNF Receptor Type II-IgG Fusion Protein — Recombinant Human Dimeric TNF Receptor Type II IgG Fusion Protein